IL87658A - Tetrahydro-2- (1h-imidazolylmethyl) pyrido- (and azepino)[4,3-(b)] indol-1-ones, their preparation and pharmaceutical compositions containing them - Google Patents

Tetrahydro-2- (1h-imidazolylmethyl) pyrido- (and azepino)[4,3-(b)] indol-1-ones, their preparation and pharmaceutical compositions containing them

Info

Publication number
IL87658A
IL87658A IL8765888A IL8765888A IL87658A IL 87658 A IL87658 A IL 87658A IL 8765888 A IL8765888 A IL 8765888A IL 8765888 A IL8765888 A IL 8765888A IL 87658 A IL87658 A IL 87658A
Authority
IL
Israel
Prior art keywords
methyl
group
compound
indol
formula
Prior art date
Application number
IL8765888A
Other languages
English (en)
Other versions
IL87658A0 (en
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB878720695A external-priority patent/GB8720695D0/en
Priority claimed from GB888819382A external-priority patent/GB8819382D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of IL87658A0 publication Critical patent/IL87658A0/xx
Publication of IL87658A publication Critical patent/IL87658A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL8765888A 1987-09-03 1988-09-02 Tetrahydro-2- (1h-imidazolylmethyl) pyrido- (and azepino)[4,3-(b)] indol-1-ones, their preparation and pharmaceutical compositions containing them IL87658A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878720695A GB8720695D0 (en) 1987-09-03 1987-09-03 Chemical compounds
GB888819382A GB8819382D0 (en) 1988-08-15 1988-08-15 Lactame derivatives

Publications (2)

Publication Number Publication Date
IL87658A0 IL87658A0 (en) 1989-02-28
IL87658A true IL87658A (en) 1994-06-24

Family

ID=26292675

Family Applications (1)

Application Number Title Priority Date Filing Date
IL8765888A IL87658A (en) 1987-09-03 1988-09-02 Tetrahydro-2- (1h-imidazolylmethyl) pyrido- (and azepino)[4,3-(b)] indol-1-ones, their preparation and pharmaceutical compositions containing them

Country Status (15)

Country Link
EP (1) EP0306323B1 (de)
AT (1) ATE111910T1 (de)
AU (1) AU613662B2 (de)
CY (1) CY1789A (de)
CZ (1) CZ404491A3 (de)
DE (1) DE3851597T2 (de)
ES (1) ES2060655T3 (de)
GB (1) GB2209335B (de)
HK (1) HK75591A (de)
HU (1) HU211843A9 (de)
IE (1) IE61669B1 (de)
IL (1) IL87658A (de)
NZ (1) NZ226032A (de)
PH (1) PH25493A (de)
SK (1) SK404491A3 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4672117A (en) * 1985-09-16 1987-06-09 American Home Products Corporation Antipsychotic gamma-carbolines
US4636563A (en) * 1985-09-16 1987-01-13 American Home Products Corporation Antipsychotic γ-carbolines
DE3822792C2 (de) * 1987-07-11 1997-11-27 Sandoz Ag Neue Verwendung von 5HT¶3¶-Antagonisten
EP0339959A3 (de) * 1988-04-27 1991-03-20 Glaxo Group Limited Laktam-Derivate
HU207078B (en) * 1988-08-02 1993-03-01 Glaxo Group Ltd Process for producing lactam derivatives and pharmaceutical compositions comprising such compounds
IL91167A (en) * 1988-08-02 1993-06-10 Glaxo Group Ltd Substituted 2-(imidazolymethyl)-pyrido- (and azepino-) indol-1-one derivatives, their preparation and pharmaceutical compositions containing them
EP0356098A3 (de) * 1988-08-15 1990-07-25 Glaxo Group Limited Lactamderivate
GB8820650D0 (en) * 1988-09-01 1988-10-05 Glaxo Group Ltd Medicaments
GB8820653D0 (en) * 1988-09-01 1988-10-05 Glaxo Group Ltd Medicaments
US4997831A (en) * 1988-09-01 1991-03-05 Glaxo Group Limited Lactam derivatives
GB8820651D0 (en) * 1988-09-01 1988-10-05 Glaxo Group Ltd Medicaments
EP0377238A1 (de) * 1988-12-22 1990-07-11 Duphar International Research B.V Annelierte Indolo(3,2-c)-lactame
US5223625A (en) * 1988-12-22 1993-06-29 Duphar International Research B.V. Annelated indolo [3,2,-C]lactams
HU204049B (en) * 1989-02-28 1991-11-28 Glaxo Group Ltd Process for producing lactam derivatives and pharmaceutical compositions comprising same
GB8904552D0 (en) * 1989-02-28 1989-04-12 Glaxo Group Ltd Chemical process
GB8904551D0 (en) * 1989-02-28 1989-04-12 Glaxo Group Ltd Chemical compounds
KR900013959A (ko) * 1989-03-13 1990-10-22 원본미기재 γ-카르블린 또는 그들의 제약학적으로 허용 가능한 산부가염 및/또는 수화물, 및 그들로 구성되는 제약학적 조성물
NZ233285A (en) * 1989-04-18 1992-06-25 Duphar Int Res Imidazole-substituted carbamoyl-indoles and condensed analogues thereof and pharmaceutical compositions
EP0422154B1 (de) 1989-04-21 1993-12-01 Sandoz Erfindungen Verwaltungsgesellschaft M.B.H. Therapeutische verwendung von 5-ht3-rezeptor-antagonisten
US5530008A (en) * 1989-04-21 1996-06-25 Sandoz Ltd. Use of 5-HT3 receptor antagonists in treating panic disorders or obsessive compulsive disorders
GB8913646D0 (en) * 1989-06-14 1989-08-02 Glaxo Group Ltd Chemical compounds
US5276050A (en) * 1989-08-01 1994-01-04 Glaxo Group Limited Medicaments
GB8917557D0 (en) * 1989-08-01 1989-09-13 Glaxo Group Ltd Medicaments
US5180728A (en) * 1989-09-25 1993-01-19 Fujisawa Pharmaceutical Company, Ltd. Pyrimidoindole derivatives and processes for preparation thereof
GB8928208D0 (en) * 1989-12-13 1990-02-14 Glaxo Group Ltd Medicaments
GB8928837D0 (en) * 1989-12-21 1990-02-28 Beecham Group Plc Pharmaceuticals
GB9011469D0 (en) * 1990-05-23 1990-07-11 Glaxo Group Ltd Chemical process
US5229517A (en) * 1990-09-27 1993-07-20 Hoechst-Roussel Pharmaceuticals Incorporated 2-(4-Piperindinyl)-1H-pyrido[4,3-B]indol-1-ones and related compounds
US5102889B1 (en) * 1990-09-27 1993-05-11 2-(4-piperidinyl)-1h-pyrido(4,3-b)indol-1-ones and related compounds
US5189041A (en) * 1990-11-16 1993-02-23 Syntex (U.S.A.) Inc. Tricyclic 5-ht3 receptor antagonists
GB9721139D0 (en) 1997-10-07 1997-12-03 Glaxo Group Ltd Medicaments
WO2001058869A2 (en) * 2000-02-11 2001-08-16 Bristol-Myers Squibb Company Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators in treating respiratory and non-respiratory diseases
CA2473392A1 (en) 2002-01-18 2003-07-31 Aryx Therapeutics 5-ht3 receptor antagonists and methods of use
RU2544856C2 (ru) 2008-01-25 2015-03-20 Сергей Олегович Бачурин НОВЫЕ ПРОИЗВОДНЫЕ 2,3,4,5-ТЕТРАГИДРО-1-ПИРИДО[4,3-b]ИНДОЛА И СПОСОБЫ ИХ ПРИМЕНЕНИЯ
ES2432618T3 (es) 2009-05-20 2013-12-04 Inserm (Institut National De La Santé Et De La Recherche Medicale) Antagonistas del receptor 5-HT3 de serotonina para usar en el tratamiento o prevención de una patología del oído interno con déficit vestibular
HUE037300T2 (hu) 2009-05-20 2018-08-28 Inst Nat Sante Rech Med Szerotonin 5-HT3 receptor antagonisták lezionális vesztibuláris zavarok kezelésében való felhasználásra

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0191562B1 (de) * 1985-01-23 1991-07-10 Glaxo Group Limited Tetrahydrocarbazolonderivate
IL91167A (en) * 1988-08-02 1993-06-10 Glaxo Group Ltd Substituted 2-(imidazolymethyl)-pyrido- (and azepino-) indol-1-one derivatives, their preparation and pharmaceutical compositions containing them
HU204049B (en) * 1989-02-28 1991-11-28 Glaxo Group Ltd Process for producing lactam derivatives and pharmaceutical compositions comprising same

Also Published As

Publication number Publication date
PH25493A (en) 1991-07-24
EP0306323A2 (de) 1989-03-08
AU613662B2 (en) 1991-08-08
ES2060655T3 (es) 1994-12-01
ATE111910T1 (de) 1994-10-15
CZ404491A3 (en) 1993-04-14
AU2174288A (en) 1989-03-09
HK75591A (en) 1991-10-04
EP0306323B1 (de) 1994-09-21
GB8820736D0 (en) 1988-10-05
NZ226032A (en) 1991-12-23
DE3851597D1 (de) 1994-10-27
DE3851597T2 (de) 1995-01-26
SK404491A3 (en) 2000-12-11
IE882669L (en) 1989-03-03
GB2209335B (en) 1991-05-29
GB2209335A (en) 1989-05-10
IL87658A0 (en) 1989-02-28
CY1789A (en) 1995-10-20
EP0306323A3 (en) 1990-07-18
IE61669B1 (en) 1994-11-16
HU211843A9 (en) 1995-12-28

Similar Documents

Publication Publication Date Title
IL87658A (en) Tetrahydro-2- (1h-imidazolylmethyl) pyrido- (and azepino)[4,3-(b)] indol-1-ones, their preparation and pharmaceutical compositions containing them
CA1336906C (en) Lactam derivatives
US5045545A (en) [(Imidazol-4(and 5)-yl)methyl] tetracyclic ketones having 5-HT3 antagonist activity
EP0339959A2 (de) Laktam-Derivate
US4859662A (en) Tetrahydro-imidazolylmethylcarbazolones and analogs thereof for treating 5-HT function disturbances
US5360800A (en) Tetrahydro-1H-pyrido[4,3-b]indol-1-one derivatives
US5183820A (en) Lactam derivatives
US4918080A (en) Imidazollyl containing ketone derivatives
US5116984A (en) Imidazole derivatives
US5008272A (en) Lactam derivatives
US5019586A (en) Ketone derivatives
CA1339022C (en) Lactam derivatives
JP2602915B2 (ja) ラクタム誘導体
CA1330536C (en) Medicament for the treatment of a cognitive disorder
US5202343A (en) Tricyclic ketones useful as HT3 -receptor antagonists
EP0345956B1 (de) Tricyclische Ketone
CA1330535C (en) Medicament for treating depression
US5221687A (en) Medicaments
US5229407A (en) Medicaments
EP0357416A2 (de) Verwendung von Serotonin-Antagonisten bei der Behandlung von Drogenabhängigkeit
NZ232598A (en) Imidazolylmethyl tetracyclic lactam derivatives and pharmaceutical compositions

Legal Events

Date Code Title Description
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees